Skip to main content
Equibles
PBH logo

PBH · Prestige Consumer Healthcare Inc. · Metrics

Track PBH — free

Use PBH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PBH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$49.25 -0.11 (-0.22%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.34B
Shares
47.37M
Volume · Oct 20 536.75K Avg daily vol (3M) 554.89K

PBH metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$49.36
Market cap
$2.34B

Price action

20 metrics
Price change (1W)
+1.8%
Price change (30D)
+5.5%
Price change (3M)
+0.7%
Price change (6M)
-14.2%
Price change (YTD)
-20.0%
Price change (1Y)
-20.6%
Trailing year
Price change (5Y)
-16.4%
52-week high
$70.21
52-week low
$44.77
Change from 52-week high
-29.7%
Change from 52-week low
+10.3%
Annualized volatility
32.4%
Annualized volatility (3M)
31.2%
Beta
0.0
RSI (14D)
56.8
Price vs SMA 50
+0.7%
Price vs SMA 200
-9.8%
Avg volume (3M)
554,889
Relative volume
1.0
Average dollar volume
$27.36M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
47.37M

Valuation

12 metrics
P / E (TTM)
13.8
Trailing earnings · reciprocal yield 7.2%
PEG ratio
—
EV / revenue
3.9×
reciprocal yield 25.8%
EV / EBITDA
13.3×
reciprocal yield 7.5%
EV / EBIT
14.8×
reciprocal yield 6.8%
P / sales
2.1×
reciprocal yield 46.9%
P / book
1.2
reciprocal yield 81.4%
FCF yield
10.0%
TTM · current market cap
Buyback yield
5.2%
P / FCF
10.0
reciprocal yield 10.0%
P / operating cash flow
9.4
reciprocal yield 10.6%
Earnings yield
7.3%

Historical valuation

8 metrics
P / E historical average (3Y)
16.8×
reciprocal yield 6.0%
P / E historical average (5Y)
16.1×
reciprocal yield 6.2%
EV / revenue historical average (3Y)
3.9×
reciprocal yield 25.5%
EV / revenue historical average (5Y)
4.0×
reciprocal yield 25.2%
EV / EBIT historical average (3Y)
13.5×
reciprocal yield 7.4%
EV / EBIT historical average (5Y)
13.5×
reciprocal yield 7.4%
EV / EBITDA historical average (3Y)
103.0×
reciprocal yield 1.0%
EV / EBITDA historical average (5Y)
106.2×
reciprocal yield 0.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
5.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
53.5%
Operating margin
26.3%
Trailing 12 months
Net margin
15.6%
Gross profit (TTM)
$591.43M
Operating profit (TTM)
$290.17M
Net income (TTM)
$172.01M
Trailing 12 months
Diluted EPS (TTM)
$3.57
FCF margin
21.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$22.95
Gross profit per diluted share (TTM)
$12.28
Operating profit per diluted share (TTM)
$6.02
EBITDA per diluted share (TTM)
$6.69
Net income per diluted share (TTM)
$3.57
Operating cash flow per diluted share (TTM)
$5.18
Free cash flow per diluted share (TTM)
$4.89
Capital expenditures per diluted share (TTM)
$0.29
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.23
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.5%
Year over year
Net income growth YoY
-38.5%
Revenue (TTM)
$1.10B
Trailing 12 months
EPS growth YoY
-35.8%
Shares change YoY
-4.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.2%
Revenue CAGR (5Y)
+2.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+3.8%
FCF CAGR (3Y)
+3.6%
FCF CAGR (5Y)
+2.9%

Quality

14 metrics
Return on equity
9.0%
Return on assets
3.8%
Debt / equity
1.1
Current ratio
3.2
EBITDA (TTM)
$322.53M
Free cash flow (TTM)
$235.36M
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
6.0
Return on invested capital
—
Trailing 12 months
Net cash
−$1.93B
Latest balance sheet
Cash & equivalents
$89.13M
Total assets
$4.57B
Total debt
$2.02B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$249.40M
Capital expenditures (TTM)
$14.04M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$11.15M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

9 metrics
13F filers
320
13F filer change QoQ
-34
Institutional ownership
113.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.9%
Holder tenure
15.5
Price vs estimated holder cost
-23.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
29.9%

Short interest

3 metrics
Short interest
9.8%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1295947 CUSIP 74112D101 13F (30d) 37 filings 36 filers Visit website Investor relations